非手术性症状膝关节骨关节炎的治疗之旅:来自新现实世界注册表的数据
Andrew I Spitzer1, Michael A Mont2, Jennifer H Lin3
1Department of Orthopaedic Surgery, Cedars Sinai Medical Center, Los Angeles, California.
Surgical technology international
|March 21, 2025
概括
膝关节骨关节炎 (OA) 的关节内延长释放型氨 (IA-TAER) 注射显示重复治疗率比其他非手术选择高 (73%). 在这项研究中,在重复使用IA-TAER时没有报告任何不良事件.
科学领域:
- 整形外科 整形外科 整形外科
- 疼痛管理 疼痛管理
- 再生医学是一种再生医学.
背景情况:
- 膝关节骨关节炎 (OA) 管理涉及各种非手术治疗.
- 了解治疗序列和重复使用对于优化患者护理至关重要.
研究的目的:
- 为膝盖骨关节炎患者定义治疗顺序,接受多达四轮非手术干预.
- 为了比较延长释放和标准皮质类固醇注射的使用情况.
- 量化膝关节OA重复非手术治疗的分布.
主要方法:
- 一组502名患有症状膝关节骨关节炎的患者从基因结局创新 (IGOR) 注册表 (2021-2024) 中被确定.
- 分析了治疗过程,包括重复使用的序列,持续时间和频率.
- 使用描述性统计数据来估计初始治疗的重复使用.
主要成果:
- 53%的患者仅接受了最初的第一轮治疗.
- 73%的患者接受了关节内延长释放型氨 (IA-TAER) 治疗,重复治疗,而其他治疗的患者则为60%.
- 在重复治疗期间没有报告任何不良事件.
结论:
- 接受IA-TAER的患者更有可能重复注射,其中73%的人至少重复一次.
- 大约一半的患者在随访期间从初始治疗中转换.
- 使用IA-TAER与较高的膝关节OA重复治疗率有关,没有观察到任何不良事件.
相关概念视频
Clinical Trials: Overview
2.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.6K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
140
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
140
Knee Joint
1.4K
The knee joint is the most complicated joint in the body. It consists of three articulations– two tibiofemoral and one patellofemoral. As is characteristic of synovial joints, the knee joint has a thin articular capsule that partially surrounds this joint cavity. Additionally, several ligaments, muscles, and cartilaginous structures support the movement of the knee.
A total of seven ligaments support the knee joint. The patellar ligament, which is also attached to the quadriceps femoris...
A total of seven ligaments support the knee joint. The patellar ligament, which is also attached to the quadriceps femoris...
1.4K
Drug Administration and Therapy Phases: Overview
401
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
401
Inflammatory Bowel Disease V: Surgical Management
71
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
71


